CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Oyster Point Pharma, Inc.

OYST
N/A

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for OYST. That does not mean none is planned.

Get an email about OYST's next catalysts

Track Oyster Point Pharma (OYST) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQBiotechnologyπŸ‡ΊπŸ‡ΈNorth America

Frequently asked questions

What is in Oyster Point Pharma, Inc.'s drug pipeline?β†’

CatalystAlert tracks 11 drug candidates in Oyster Point Pharma, Inc.'s (OYST) pipeline across Phase 3, Phase 2. Its lead program is OC-01 (varenicline) nasal spray (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Oyster Point Pharma, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Oyster Point Pharma, Inc. (OYST) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track OYST biotech catalysts?β†’

Add OYST to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Oyster Point Pharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply